Economic burden associated with adverse events in patients with metastatic melanoma

There are currently many approved agents for the treatment of metastatic melanoma (MM), the most aggressive form of skin cancer. Treatments may include systemic therapies such as ipilimumab, dacarbazine, temozolomide, high-dose interleukin 2, interferon α, dacarbazine- or temozolomide-based combinat...

Full description

Bibliographic Details

Published in:	Journal of managed care & specialty pharmacy Vol. 21; no. 2; p. 158
Main Authors:	Arondekar, Bhakti, Curkendall, Suellen, Monberg, Matthew, Mirakhur, Beloo, Oglesby, Alan K, Lenhart, Gregory M, Meyer, Nicole
Format:	Journal Article
Language:	English
Published:	United States 01.02.2015
Subjects:	Adult Aged Antineoplastic Agents - adverse effects Cost of Illness Female Health Care Costs Humans Male Melanoma - drug therapy Melanoma - economics Melanoma - pathology Middle Aged Neoplasm Metastasis
ISSN:	2376-1032, 2376-1032
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!